MYC and triple-negative breast carcinoma: 219 Horiuchi Horiuchi D. D. Kusdra Kusdra L. L. Huskey Huskey N.E. N.E. Chandriani Chandriani S. S. Lenburg Lenburg M.E. M.E. Gonzalez-Angulo Gonzalez-Angulo A.M. A.M. Creasman Creasman K.J. K.J. Bazarov Bazarov A.V. A.V. Smyth Smyth J.W. J.W. Davis Davis S.E. S.E. Yaswen Yaswen P. P. Mills Mills G.B. G.B. Esserman Esserman L.J. L.J. Goga Goga A. A. MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition J. Exp.